TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in TScan Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- 0 vs. Q1 2023
- Shares held
- 28.0M
- +18.3M (+189.1%) vs. Q1 2023
- Total value
- $69.9M
- +$49.6M (+244.1%) vs. Q1 2023
- New holders
- 5
- 8 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 80 | $200 | 0.00% | +5+6.7% | Added |
| Bank of America Corp | 200 | $500 | 0.00% | 00.0% | Unchanged |
| Atlas Capital Advisors LLC | 896 | $2.24K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,100 | $2.75K | 0.00% | −2,140−66.0% | Reduced |
| Waldron Private Wealth LLC | 10,000 | $25.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,055 | $37.6K | 0.00% | +905+6.4% | Added |
| Privium Fund Management (UK) Ltd | 15,825 | $40.0K | 0.03% | 00.0% | Unchanged |
| DC Investments Management, LLC | 35,563 | $88.9K | 0.10% | 00.0% | Unchanged |
| State Street Corp | 38,500 | $96.3K | 0.00% | +14,500+60.4% | Added |
| Bridgeway Capital Management, LLC | 50,000 | $125.0K | 0.00% | −65,000−56.5% | Reduced |
| NewEdge Wealth, LLC | 91,463 | $228.7K | 0.01% | 00.0% | Unchanged |
| Stifel Financial Corp | 99,000 | $247.5K | 0.00% | +99,000 | New |
| Morgan Stanley | 108,475 | $271.2K | 0.00% | −22,844−17.4% | Reduced |
| Geode Capital Management, LLC | 116,891 | $292.2K | 0.00% | +16,449+16.4% | Added |
| Renaissance Technologies LLC | 147,462 | $369.0K | 0.00% | +135,862+1,171.2% | Added |
| Tekla Capital Management LLC | 200,000 | $500.0K | 0.02% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 400,000 | $1.00M | 0.24% | +400,000 | New |
| DC Funds, LP | 630,000 | $1.57M | 33.55% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $2.62M | 0.47% | +500,000+91.4% | Added |
| Alphabet Inc. | 1,077,080 | $2.69M | 0.14% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,505 | $3.11M | 0.28% | 00.0% | Unchanged |
| BlackRock Inc. | 1,263,453 | $3.16M | 0.00% | −251,597−16.6% | Reduced |
| Vanguard Group Inc | 1,359,289 | $3.40M | 0.00% | +1,062,464+357.9% | Added |
| Baker Bros. Advisors LP | 2,784,792 | $6.96M | 0.04% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $7.47M | 0.21% | +2,989,474 | New |
| Adage Capital Partners GP, L.L.C. | 4,000,000 | $10.0M | 0.02% | +3,450,000+627.3% | Added |
| EcoR1 Capital, LLC | 5,000,000 | $12.5M | 0.33% | +5,000,000 | New |
| Lynx1 Capital Management LP | 5,224,600 | $13.1M | 8.56% | +5,224,600 | New |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −236,800−100.0% | Sold out |
| Cannell Capital LLC | 0 | $0 | 0.00% | −14,666−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,147−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |